Back

Comparative cardiovascular outcomes of semaglutide versus tirzepatide in patients with atrial fibrillation undergoing catheter ablation: a retrospective cohort study

30 August 2026 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation: outcomes and clinical complexity Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mohamed Shelig

Marshall University, Huntington (United States of America)

4 More presentations in this session

Presentation thumbnail
Catheter ablation and clinical outcomes in octogenarians with paroxysmal atrial fibrillation
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Clinical and socioeconomic inequalities in access to catheter ablation of atrial fibrillation: a nationwide cohort study, spanning 15 years
Ms S. Klaveback (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation ablation versus transcatheter edge-to-edge mitral valve repair as first-line therapy in atrial fibrillation with functional mitral regurgitation
Doctor H. El-Shirbiny (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
In-hospital outcomes of atrial fibrillation catheter ablation in patients with baseline anemia or thrombocytopenia: a nationwide analysis from the National Inpatient Sample (2016–2021)
Doctor G. Margolis (Hadera, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: outcomes and clinical complexity

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonist use and clinical outcomes after atrial fibrillation ablation: a 110-center real-world analysis
29 August 2026
thumbnail
Congress Presentation
Comparison of cardiovascular outcomes in patients with diabetes treated with tirzepatide versus semaglutide: a multi-institutional analysis
31 August 2024
thumbnail
Congress Presentation
Head to head comparison of semaglutide and colchicine for treating atrial remodeling in post-MI rats with reduced ejection fraction
29 August 2025
thumbnail
Congress Presentation
Semaglutide and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources